Calgon Bio-Organics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 59.25%
- Profit Growth 49.24%
- Ebitda 8.02%
- Net Worth 14.85%
- Total Assets 0.30%
About Calgon Bio-Organics
Calgon Bio-Organics Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 February 2012 and has a history of 13 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohd Ahmed, Naseem Akthar, and Atika Nasreen serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233TG2012PTC079046
- Company No.
079046
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Calgon Bio-Organics Private Limited offer?
Calgon Bio-Organics Private Limited offers a wide range of products and services, including Material Testing Labs & Services, Testing Services.
Who are the key members and board of directors at Calgon Bio-Organics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohd Ahmed  | Director | 09-Feb-2012 | Current |
| Naseem Akthar | Director | 09-Feb-2012 | Current |
| Atika Nasreen | Director | 09-Feb-2012 | Current |
Financial Performance of Calgon Bio-Organics.
Calgon Bio-Organics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 59.25% increase. The company also saw a substantial improvement in profitability, with a 49.24% increase in profit. The company's net worth Soared by an impressive increase of 14.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Calgon Bio-Organics?
In 2017, Calgon Bio-Organics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unizak Infotech Private LimitedMohd Ahmed and Atika Nasreen are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Calgon Bio-Organics?
Unlock and access historical data on people associated with Calgon Bio-Organics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Calgon Bio-Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Calgon Bio-Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.